Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension.
<h4>Background & aims</h4>Official guidelines do not recommend hepatic resection (HR) for patients with hepatocellular carcinoma (HCC) and portal hypertension (PHT). This study aims to investigate the safety and efficacy of HR for patients with HCC and PHT.<h4>Methods</h4>...
Guardado en:
Autores principales: | Jian-Hong Zhong, Hang Li, Nan Xiao, Xin-Ping Ye, Yang Ke, Yan-Yan Wang, Liang Ma, Jie Chen, Xue-Mei You, Zhi-Yuan Zhang, Shi-Dong Lu, Le-Qun Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5dc2de09d63a4298b451ea5c33ad5325 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention
por: Yoshihiro Ono, et al.
Publicado: (2021) -
Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
por: Xinyu Chen, et al.
Publicado: (2021) -
Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.
por: Jian-Hong Zhong, et al.
Publicado: (2013) -
Clinical features and prognosis of primary myelofibrosis with hepatic vascular disease and/or portal hypertension
por: WANG Jing
Publicado: (2021) -
Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kylie E. Zane, et al.
Publicado: (2021)